focus -WSS

focus

author：fashion 2025-09-30 15:16:25 - browse：38175

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： STAT Madness 2024: Meet the contenders

hotspot

explore

WSS

Study fuels hope CAR

FTC falls short on scrutinizing hospital mergers, study says

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Cholera vaccine supply gets boost as demand surges globally

Orangutan used medicinal plant to treat wound, first time ever seen

Wikipedia

focus

Wikipedia

Virginia high school admissions case could be legal follow

Dogs on Prozac: What pet anti

As demand for Covid shots wanes, Moderna seeks its next success

Change Healthcare cyberattack shows risk of industry consolidation

How to save PrEP access — and even expand it

Bird flu in milk supply is likely coming from asymptomatic cows

Virginia high school admissions case could be legal follow

Element Biosciences CEO lays out genome sequencing strategy

Cancer drug shortages should be causing more outrage

Cell therapy fails to slow type 1 diabetes, but safety is established

leisure time

Cell therapy fails to slow type 1 diabetes, but safety is established

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

H5N1 bird flu virus started spreading in cows in Texas in December

Pfizer is about to make a big push in cancer. Will investors listen?

Dogs on Prozac: What pet anti

Exact Sciences stock tumbles despite strong cancer detection sales

Wikipedia

hotspot

explore

hotspot